Stem cell therapy offers a minimally invasive alternative to joint replacement surgery, with recovery times of just one to two weeks compared to months for major surgery Clinical studies show varying ...

Motixafortide alone and in combination with natalizumab can support the collection of the large number of stem cells required by gene therapies for sickle cell disease within a single apheresis cycle ...